Premium
Low‐dose aspirin shows no preventive benefit for depression in elderly
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30628
Subject(s) - aspirin , medicine , depression (economics) , low dose aspirin , placebo , primary prevention , intensive care medicine , alternative medicine , disease , pathology , economics , macroeconomics
Low‐dose aspirin demonstrated no significant effect in preventing depression compared with placebo in a study that examined aspirin's potential preventive benefits for several conditions in elderly individuals. The evidence base for primary preventive strategies to combat depression remains severely limited.